Seeking Alpha

Dennis R. Mahon

Dennis R. Mahon
Send Message
View as an RSS Feed
View Dennis R. Mahon's Comments BY TICKER:
Latest  |  Highest rated
  • New Story On Second Sight Shows The Technology Is Gaining Traction [View article]
    Get confident. I believe in $EYES. Game changer. Raising money, IF NECESSARY... should not be a problem. Oh geez... maybe I'm too much in love with this stock. But I don't think so. Vision to be saved, money to be made. My Mom's eyes were failing, fortunately didn't go completely blind before passing at a nice old age. But $EYES might save so much eyesight in the future. Blindness would be my biggest fear. I just love to see. Who doesn't. Tell me who would give up some other sense first. Hearing... touch... smell... feel... probably not. The "color sense" known as "sight", as a totally blind from birth friend put it... trumps all, one would think. That's why I love this company. I makes so much sense. GLTA.
    Apr 22, 2015. 03:26 PM | 2 Likes Like |Link to Comment
  • New Story On Second Sight Shows The Technology Is Gaining Traction [View article]
    Mr. Hoffmann...I'm honored to respond to the SA editor and say... as a shareholder, I am confident that $EYES management will seek a most favorable way to raise money... IF NEEDED. After all, Al Mann is a driving force and can chip in IF NEEDED. The technology is game changing, and I look forward to a great year, and years to come. I sincerely doubt that management will be forced to raise money on unfavorable terms.

    By the way Mr. Hoffman... I love this site and it's nice to see your increased presence. Let us go forward and prosper, all together.
    Apr 22, 2015. 03:12 PM | 3 Likes Like |Link to Comment
  • Tonix Shares Looking Attractive As Clinical Programs Advance Forward [View article]
    Just to simplify this... you type in the symbol $TNXP, or any symbol for that matter, or click on any symbol in your portfolio on SA... it'll take you to a devoted page... and click on "Stocktalks" and you will see all the latest stocktalks on that stock. I like that a lot... do it for many stocks every day.
    Apr 16, 2015. 03:11 PM | 1 Like Like |Link to Comment
  • New Story On Second Sight Shows The Technology Is Gaining Traction [View article]
    Thanks again Edward. My impression is that EYES patients will "see" much better as the number of pixels they can "see" increases, and that that can be happening very soon... just with external software upgrades... no need for any more operations... what's implanted now can be upgraded which is very exciting. Such as, 64 pixels now... 10 times that very soon, and many more times that to come. That could make a huge difference in what patients are seeing. Love the pixels. More pixels, more real sight. Thanks again for the article and your response.
    Apr 15, 2015. 04:58 PM | Likes Like |Link to Comment
  • New Story On Second Sight Shows The Technology Is Gaining Traction [View article]
    Thanks for the update Edward. Question: I gather $EYES is working on software upgrades to greatly enlarge the number of pixels patients can "see"... so those patients who already have the implant may see more and more in the future. Is that your impression, and if so, how soon may this happen. Thanks so much.
    Apr 15, 2015. 03:11 PM | Likes Like |Link to Comment
  • Omeros Is Undervalued, Omidria Shows Great Promise [View article]
    Thanks so much Alan Robert Ross! Fine article. Most interesting. This will likely be in my portfolio soon. And thanks for your continuing coverage of $PVCT.
    Apr 8, 2015. 04:15 PM | 3 Likes Like |Link to Comment
  • Provectus And The Long Silence [View article]
    May your Mom live long and well! Thurman, if you love PV-10 for what it has done to help your Mom, perhaps somewhere during or after the Phase III trial you will buy some $PVCT shares, and if so, let us know when you do.
    Mar 10, 2015. 02:40 PM | 3 Likes Like |Link to Comment
  • The Provectus PV-10 Dilemma [View article]
    Please, ikarus... share what led you to pronounce this $PVCT "a donut" today. Why today... and why "a donut" and if a donut, what kind. I think it's more like an apple fritter, which is bigger, and tastier. Very tasty. Buy now.
    Mar 5, 2015. 12:37 PM | 1 Like Like |Link to Comment
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    You are so right. I like your ideas Robert... there was a lot of money to be made with $MNKD in the past, and likely more in the future. I sold 40% at $7.50 the other day... may be buying that stake back at the right price. I'm not a natural trader... but this stock has driven me crazy... so a little trading might help me make a little money. So far it's been OK... but I sure should have sold a bunch just before approval of Afrezza. Ah well, live, learn, love Afrezza. My core position is intact. GLTA of course.
    Feb 12, 2015. 02:54 PM | 2 Likes Like |Link to Comment
  • Glu Mobile's 4th Quarter Surprises [View article]
    I remember that game! My kids and other relatives played the Nintendo 64 James Bond game and liked it a LOT. Hopefully, $GLUU will have a worthy game as well. Could be big. Maybe bigger than a Cristiano Ronaldo game would be. We know James Bond... he's sold pretty well over the years.
    Feb 12, 2015. 02:07 PM | 1 Like Like |Link to Comment
  • Glu Mobile's 4th Quarter Surprises [View article]
    I have never heard of Cristiano Ronaldo, so personally I'm not looking forward to THAT. Guess you're talking about soccer... "futbol"... but I'm not sure, could be rugby for all I know. Come on now... maybe a Peyton Manning game for $GLUU... real "Football". But Cristiano Ronaldo... gee... maybe for soccer moms, or I guess the "rest" of the world. Not to be snarky, but "That points to one person... Cristiano Roanaldo"... just seems quite funny. I mean, when I read that comment I was, uh, who... the heck is... that person. Anyway, good luck. Glad you like $GLUU.
    Feb 12, 2015. 02:00 PM | Likes Like |Link to Comment
  • PharmaCyte Biotech (Formerly, Nuvilex): Where, Oh Where Did The Cash Flow Go... [View article]
    "PENNY PICKS" today, 2/11/15... email stock promotion letter...
    part of the disclaimer:

    "Stellar Media’s business model is to receive financial compensation to promote public companies. We have been compensated Twenty five thousand dollars cash via bank wire by a third party, Cream Consulting, LLC, to conduct investor relations advertising and marketing for PMCB. This compensation is a major conflict of interest in our ability to be unbiased regarding ."
    Feb 11, 2015. 10:41 AM | 1 Like Like |Link to Comment
  • Glu blows away estimates; guidance mixed [View news story]
    Pretty nice report with Katy Perry as the cherry on top!
    Feb 4, 2015. 04:19 PM | 3 Likes Like |Link to Comment
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    Thank you again Psycho Analyst. Great information.
    Feb 4, 2015. 09:39 AM | 1 Like Like |Link to Comment
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    Psycho, thank you for your response to my question regarding pricing. The SA news release "Sanofli Launches Afrezza" from two days ago had this as the second bullet point:

    Afrezza is priced at $7.54 for a daily dose of 12 units compared to $3.14 for Sanofi's injectable Apidra.

    That's what had me confused. I had read your previous article and did understand that Afrezza would be priced similarly to other fast acting insulins.
    But you can see where this bit of info from SA caused me confusion. I take it SA was wrong with their $7.54 vs $3.14 comparison... maybe not "apples to apples"... and I have no idea what Aprida is or if it's comparable to Afrezza.
    Feb 4, 2015. 07:56 AM | Likes Like |Link to Comment
COMMENTS STATS
444 Comments
361 Likes